|
Real-time
Euronext Paris
15:41:11 15/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 74.15 EUR | -1.70% |
|
-0.67% | -10.30% |
| 08:54am | Sanofi : Deutsche Bank reiterates its Buy rating | ZD |
| 09-14 | Sanofi and Cheplapharm Create Strategic Partnership in Mature Medicines | CI |
| Market Cap | 90.37B 104B 85.28B 77.37B 145B 9,996B 146B 1,019B 392B 5,071B 392B 383B 16,122B | P/E 2026 * |
12x | P/E 2027 * | 10.5x |
|---|---|---|---|---|---|
| Enterprise Value | 102B 118B 96.1B 87.18B 164B 11,264B 165B 1,148B 442B 5,714B 441B 432B 18,167B | EV / Sales 2026 * |
2.14x | EV / Sales 2027 * | 1.95x |
| Free-Float |
88.34% | Yield 2026 * |
5.64% | Yield 2027 * | 5.96% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| SAN | Real-time | |
CBOE
| SAN | Real-time | |
|
London S.E.
| 0O59 | Delayed | |
|
Tradegate
| SNW | Real-time | |
|
Börse Stuttgart
| SNW | Delayed | |
|
Borsa Italiana
| 1SAN | End-of-day quote | |
|
Xetra
| SNW | Delayed | |
|
Boerse Muenchen
| SNW | Real-time | |
|
Wiener Boerse
| SANO | End-of-day quote | |
|
OTC Markets
| SNYNF | Delayed | |
|
Mexican S.E.
| SAN1 N | End-of-day quote | |
|
Bulgaria S.E.
| SNW | End-of-day quote | |
|
Swiss Exchange
| SAN | Delayed | |
|
CBOE
| 0O59 | Real-time | |
|
Deutsche Boerse AG
| SNW | Delayed |
Last Transcript: Sanofi
| 1 day | -1.95% | ||
| 1 week | -0.99% | ||
| Current month | -3.71% | ||
| 1 month | -3.52% | ||
| 3 months | -2.09% | ||
| 6 months | -3.33% | ||
| Current year | -10.59% |
| 1 week | 73.22 |  | 75.96 |
| 1 month | 73.22 | | 79.36 |
| Current year | 71.25 | | 84.97 |
| 1 year | 71.25 | | 91.15 |
| 3 years | 71.25 | | 110.88 |
| 5 years | 71.25 | | 110.88 |
| 10 years | 62.88 | | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 30/04/2026 | |
| Director of Finance/CFO | 64 | 31/03/2024 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 29/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 57 | 27/04/2020 |
Lise Kingo
BRD | Director/Board Member | 65 | 27/04/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/08/26 | Buy | Chief Executive Officer | 1,506 | 0.0001% | ||
| 20/08/26 | Buy | Head of Human Resources | 54 | 0.0000% | ||
| 20/08/26 | Buy | Executive/Senior Manager | 840 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.90% | -0.99% | -6.98% | -28.05% | 104B | |
| +1.08% | +2.16% | +53.47% | +99.46% | 1,015B | |
| -1.95% | -2.99% | +47.16% | +61.70% | 642B | |
| -0.91% | +3.62% | +18.47% | +69.47% | 463B | |
| -1.09% | +1.57% | +36.71% | +36.22% | 353B | |
| -0.83% | +0.81% | +15.40% | +22.15% | 265B | |
| -1.36% | +0.62% | +4.70% | +9.23% | 254B | |
| -1.42% | -4.28% | +37.15% | +44.35% | 206B | |
| -1.33% | -5.43% | -22.23% | -58.57% | 191B | |
| -1.15% | -2.37% | +27.21% | +89.20% | 182B | |
| Average | -1.13% | -3.05% | +21.11% | +34.52% | 367.45B | |
| Weighted average by Cap. | -0.71% | -2.16% | +32.36% | +55.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.65B 54.99B 44.97B 40.79B 76.52B 5,271B 77.08B 537B 207B 2,674B 207B 202B 8,500B | 50.64B 58.45B 47.79B 43.36B 81.34B 5,602B 81.92B 571B 220B 2,842B 220B 215B 9,035B |
| Net income | 7.48B 8.63B 7.05B 6.4B 12.01B 827B 12.09B 84.25B 32.47B 419B 32.4B 31.69B 1,334B | 8.87B 10.23B 8.37B 7.59B 14.24B 981B 14.35B 99.95B 38.52B 498B 38.44B 37.59B 1,582B |
| Net Debt | 11.46B 13.23B 10.82B 9.81B 18.41B 1,268B 18.54B 129B 49.79B 643B 49.69B 48.59B 2,045B | 8.34B 9.62B 7.87B 7.14B 13.39B 922B 13.48B 93.95B 36.2B 468B 36.13B 35.34B 1,487B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/09/26 | €74.15 | -1.70% | 664,954 |
| 14/09/26 | €75.43 | +2.96% | 2,765,071 |
| 11/09/26 | €73.26 | -0.42% | 1,432,941 |
| 10/09/26 | €73.57 | -0.90% | 1,429,996 |
| 09/09/26 | €74.24 | -0.62% | 1,877,179 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
